Oxford Nanopore Technologies plc (LON:ONT)
209.20
+0.60 (0.29%)
Oct 15, 2026, 3:38 PM GMT
LON:ONT Revenue
Oxford Nanopore Technologies had revenue of 116.70M GBP in the half year ending June 30, 2026, with 38.79% growth. This brings the company's revenue in the last twelve months to 235.00M, up 14.79% year-over-year. In the year 2025, Oxford Nanopore Technologies had annual revenue of 223.90M with 22.22% growth. That makes Oxford Nanopore Technologies the 14,267th largest company in the world by revenue and 335th in the United Kingdom.
Revenue (ttm)
235.00M
Revenue Growth
+14.79%
P/S Ratio
8.66
Revenue / Employee
178.84K
Employees
1,314
Market Cap
2.04B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 223.90M | 40.70M | 22.22% |
| Dec 31, 2024 | 183.20M | 13.53M | 7.98% |
| Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
| Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
| Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
| Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
| Dec 31, 2019 | 52.06M | 19.54M | 60.08% |
| Dec 31, 2018 | 32.52M | 18.73M | 135.88% |
| Dec 31, 2017 | 13.79M | 9.26M | 204.42% |
| Dec 31, 2016 | 4.53M | 3.78M | 507.10% |
| Dec 31, 2015 | 746.00K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Jun 30, 2009 | 361.22K | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Genus | 658.10M |
| Oxford Biomedica | 175.36M |
| Bioventix | 12.54M |
| PureTech Health | 4.80M |
| Scancell Holdings | 4.71M |
| Ondine Biomedical | 1.53M |
| Faron Pharmaceuticals Oy | 1.14M |
| 4basebio | 781.00K |
Oxford Nanopore Technologies News
- 21 hours ago - Oxford Nanopore Technologies Plc (LON:ONT) -- Positioned for Growth in Genomic Sequencing | ... - GuruFocus
- 14 days ago - Oxford Nanopore price target raised to 300 GBp from 225 GBp at RBC Capital - TheFly
- 16 days ago - Oxford Nanopore price target raised to 250 GBp from 210 GBp at Citi - TheFly
- 22 days ago - Oxford Nanopore price target raised to 210 GBp from 195 GBp at Deutsche Bank - TheFly
- 4 weeks ago - Unified Patent Court Blocks MGI Tech's CycloneSEQ Systems In Major IP Win For Oxford Nanopore - Nasdaq
- 4 weeks ago - Oxford Nanopore Technologies PLC at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
- 4 weeks ago - Oxford Nanopore Technologies Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Oxford Nanopore price target raised to 220 GBp from 190 GBp at JPMorgan - TheFly